Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial

Background and Objectives Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse betw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal on addictions 2021-09, Vol.30 (5), p.433-444
Hauptverfasser: Fishman, Marc, Wenzel, Kevin, Scodes, Jennifer, Pavlicova, Martina, Campbell, Aimee N. C., Rotrosen, John, Nunes, Edward
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 444
container_issue 5
container_start_page 433
container_title The American journal on addictions
container_volume 30
creator Fishman, Marc
Wenzel, Kevin
Scodes, Jennifer
Pavlicova, Martina
Campbell, Aimee N. C.
Rotrosen, John
Nunes, Edward
description Background and Objectives Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups. Methods This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression. Results Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions. Conclusions and Scientific Significance No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12)
doi_str_mv 10.1111/ajad.13176
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8429062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AJAD13176</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYmNw4QegnJE6kiZNWw5IZR98aNIObBKcoixJt0xtMyUdsH9PRwHBBV9sy68fWy8A5xj1cRNXYi1UHxMcswPQxVGIA0RSfNjUKIoCRFPWASfer1ETScqOQYdQFEeM0i4Qo3dRmkrUxlbQ5nBgndOFqLXfd9P5EE63tbRl05sKvthttYSZ2ha1v4ZPWtpKCbeDWSWKnTcejp0tYb3S8Pl2OoMzZ0RxCo5yUXh99pV7YD4ezQb3wWR69zDIJoGkIWKBjgkTIYokIgmK8zREmuZhLBChOQqJIkqwRLIUK7LIpZIppfkijhlRiZQxxqQHblruZrsotZK6qp0o-MaZsnmRW2H430llVnxpX3lCwxSxsAFctgDprPdO5z-7GPG90XxvNP80uhFf_L72I_12thHgVvBmCr37B8Wzx2zYQj8AO4OJJg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Fishman, Marc ; Wenzel, Kevin ; Scodes, Jennifer ; Pavlicova, Martina ; Campbell, Aimee N. C. ; Rotrosen, John ; Nunes, Edward</creator><creatorcontrib>Fishman, Marc ; Wenzel, Kevin ; Scodes, Jennifer ; Pavlicova, Martina ; Campbell, Aimee N. C. ; Rotrosen, John ; Nunes, Edward</creatorcontrib><description>Background and Objectives Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups. Methods This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression. Results Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions. Conclusions and Scientific Significance No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12)</description><identifier>ISSN: 1055-0496</identifier><identifier>EISSN: 1521-0391</identifier><identifier>DOI: 10.1111/ajad.13176</identifier><identifier>PMID: 34075644</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Analgesics, Opioid - therapeutic use ; Buprenorphine, Naloxone Drug Combination - therapeutic use ; Delayed-Action Preparations - therapeutic use ; Humans ; Naltrexone - therapeutic use ; Opiate Substitution Treatment ; Opioid-Related Disorders - drug therapy ; Young Adult</subject><ispartof>The American journal on addictions, 2021-09, Vol.30 (5), p.433-444</ispartof><rights>2021 American Academy of Addiction Psychiatry</rights><rights>2021 American Academy of Addiction Psychiatry.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</citedby><cites>FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</cites><orcidid>0000-0002-6299-7569 ; 0000-0003-4247-9980 ; 0000-0001-6764-6410 ; 0000-0002-2055-3425</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fajad.13176$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fajad.13176$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34075644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fishman, Marc</creatorcontrib><creatorcontrib>Wenzel, Kevin</creatorcontrib><creatorcontrib>Scodes, Jennifer</creatorcontrib><creatorcontrib>Pavlicova, Martina</creatorcontrib><creatorcontrib>Campbell, Aimee N. C.</creatorcontrib><creatorcontrib>Rotrosen, John</creatorcontrib><creatorcontrib>Nunes, Edward</creatorcontrib><title>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</title><title>The American journal on addictions</title><addtitle>Am J Addict</addtitle><description>Background and Objectives Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups. Methods This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression. Results Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions. Conclusions and Scientific Significance No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12)</description><subject>Aged</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Buprenorphine, Naloxone Drug Combination - therapeutic use</subject><subject>Delayed-Action Preparations - therapeutic use</subject><subject>Humans</subject><subject>Naltrexone - therapeutic use</subject><subject>Opiate Substitution Treatment</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Young Adult</subject><issn>1055-0496</issn><issn>1521-0391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PwzAMhiMEYmNw4QegnJE6kiZNWw5IZR98aNIObBKcoixJt0xtMyUdsH9PRwHBBV9sy68fWy8A5xj1cRNXYi1UHxMcswPQxVGIA0RSfNjUKIoCRFPWASfer1ETScqOQYdQFEeM0i4Qo3dRmkrUxlbQ5nBgndOFqLXfd9P5EE63tbRl05sKvthttYSZ2ha1v4ZPWtpKCbeDWSWKnTcejp0tYb3S8Pl2OoMzZ0RxCo5yUXh99pV7YD4ezQb3wWR69zDIJoGkIWKBjgkTIYokIgmK8zREmuZhLBChOQqJIkqwRLIUK7LIpZIppfkijhlRiZQxxqQHblruZrsotZK6qp0o-MaZsnmRW2H430llVnxpX3lCwxSxsAFctgDprPdO5z-7GPG90XxvNP80uhFf_L72I_12thHgVvBmCr37B8Wzx2zYQj8AO4OJJg</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Fishman, Marc</creator><creator>Wenzel, Kevin</creator><creator>Scodes, Jennifer</creator><creator>Pavlicova, Martina</creator><creator>Campbell, Aimee N. C.</creator><creator>Rotrosen, John</creator><creator>Nunes, Edward</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6299-7569</orcidid><orcidid>https://orcid.org/0000-0003-4247-9980</orcidid><orcidid>https://orcid.org/0000-0001-6764-6410</orcidid><orcidid>https://orcid.org/0000-0002-2055-3425</orcidid></search><sort><creationdate>202109</creationdate><title>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</title><author>Fishman, Marc ; Wenzel, Kevin ; Scodes, Jennifer ; Pavlicova, Martina ; Campbell, Aimee N. C. ; Rotrosen, John ; Nunes, Edward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4206-e736a205c03807f920e4f27a034f023d3da68c691d3bfcdc944fb7763d8cc7113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Buprenorphine, Naloxone Drug Combination - therapeutic use</topic><topic>Delayed-Action Preparations - therapeutic use</topic><topic>Humans</topic><topic>Naltrexone - therapeutic use</topic><topic>Opiate Substitution Treatment</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fishman, Marc</creatorcontrib><creatorcontrib>Wenzel, Kevin</creatorcontrib><creatorcontrib>Scodes, Jennifer</creatorcontrib><creatorcontrib>Pavlicova, Martina</creatorcontrib><creatorcontrib>Campbell, Aimee N. C.</creatorcontrib><creatorcontrib>Rotrosen, John</creatorcontrib><creatorcontrib>Nunes, Edward</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal on addictions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fishman, Marc</au><au>Wenzel, Kevin</au><au>Scodes, Jennifer</au><au>Pavlicova, Martina</au><au>Campbell, Aimee N. C.</au><au>Rotrosen, John</au><au>Nunes, Edward</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial</atitle><jtitle>The American journal on addictions</jtitle><addtitle>Am J Addict</addtitle><date>2021-09</date><risdate>2021</risdate><volume>30</volume><issue>5</issue><spage>433</spage><epage>444</epage><pages>433-444</pages><issn>1055-0496</issn><eissn>1521-0391</eissn><abstract>Background and Objectives Opioid use disorder (OUD) treatment outcomes are poorer for young adults than older adults. Developmental differences are broadly implicated, but particular vulnerability factor interactions are poorly understood. This study sought to identify moderators of OUD relapse between age groups. Methods This secondary analysis compared young adults (18‐25) to older adults (26+) from a comparative effectiveness trial (“XBOT”) that randomized (N = 570) participants to extended‐release naltrexone or sublingual buprenorphine‐naloxone. We explored the relationship between 25 prespecified patient baseline characteristics and relapse to regular opioid use by age group and treatment condition, using logistic regression. Results Young adults (n = 111) had higher rates of 24‐week relapse than older adults (n = 459) (70.3% vs 58.8%) and differed on a number of specific characteristics, including more smokers, more intravenous opioid use, and more cannabis use. No significant moderators predicted relapse, in either three‐way or two‐way interactions. Conclusions and Scientific Significance No baseline factors were identified as moderating the relationship between age group and opioid relapse, nor any interactions between baseline characteristics, age group, and treatment condition to predict opioid relapse. Poorer treatment outcomes for young adults are likely associated with multiple developmental vulnerabilities rather than any single predominant factor. Although not reaching significance, several characteristics (using heroin, smoking tobacco, high levels of depression/anxiety, or treatment because of family/friends) showed higher odds ratio point estimates for relapse in young adults than older adults. This is the first study to explore moderators of worse OUD treatment outcomes in young adults, highlighting the need to identify predictor variables that could inform treatment enhancements. (Am J Addict 2021;00:1‐12)</abstract><cop>England</cop><pmid>34075644</pmid><doi>10.1111/ajad.13176</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-6299-7569</orcidid><orcidid>https://orcid.org/0000-0003-4247-9980</orcidid><orcidid>https://orcid.org/0000-0001-6764-6410</orcidid><orcidid>https://orcid.org/0000-0002-2055-3425</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1055-0496
ispartof The American journal on addictions, 2021-09, Vol.30 (5), p.433-444
issn 1055-0496
1521-0391
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8429062
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Analgesics, Opioid - therapeutic use
Buprenorphine, Naloxone Drug Combination - therapeutic use
Delayed-Action Preparations - therapeutic use
Humans
Naltrexone - therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders - drug therapy
Young Adult
title Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A29%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Examination%20of%20Correlates%20of%20OUD%20Outcomes%20in%20Young%20Adults:%20Secondary%20Analysis%20From%20the%20XBOT%20Trial&rft.jtitle=The%20American%20journal%20on%20addictions&rft.au=Fishman,%20Marc&rft.date=2021-09&rft.volume=30&rft.issue=5&rft.spage=433&rft.epage=444&rft.pages=433-444&rft.issn=1055-0496&rft.eissn=1521-0391&rft_id=info:doi/10.1111/ajad.13176&rft_dat=%3Cwiley_pubme%3EAJAD13176%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34075644&rfr_iscdi=true